Moreover, the expression levels of several top chemoresistance gene hits in colorectal cancer cells such as KEAP1, SLC43A2, or TP53 were significantly down-regulated in recurrent colorectal tumors after oxaliplatin treatment (Supplementary Fig. 2j). This evidence concerns the gene SLC43A2 and colorectal neoplasm.